MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common shares, net of...
$528,864K
(76.04%↑ Y/Y)
Proceeds from equity
incentive plans
$4,093K
(-49.74%↓ Y/Y)
Net cash provided by
financing activities
$521,532K
(71.49%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
$18,044K
(629.77%↑ Y/Y)
Canceled cashflow
$11,425K
Net change in cash,
cash equivalents and...
$150,897K
(-25.15%↓ Y/Y)
Canceled cashflow
$388,679K
Repayment of long-term
debt and finance...
$8,425K
(89.75%↑ Y/Y)
Purchase of an intangible
asset
$3,000K
Stock-based compensation
$111,223K
(36.16%↑ Y/Y)
Depreciation and
amortization
$83,701K
(129.36%↑ Y/Y)
Prepaid data assets
-$49,859K
Other receivables and
assets
-$32,939K
(-642.56%↓ Y/Y)
Lease expense
$22,249K
(33.90%↑ Y/Y)
Acquired ipr&d
$22,082K
Other, net
-$9,550K
(-25.96%↓ Y/Y)
Asset impairment
$5,956K
(5414.81%↑ Y/Y)
Loss on disposal of a
business
-$4,502K
Net cash used in
operating activities
-$371,808K
(-3.52%↓ Y/Y)
Net cash provided by
(used in) investing...
-$16,871K
(-106.49%↓ Y/Y)
Canceled cashflow
$342,061K
Other non-operating
income, net
$3,237K
(-77.23%↓ Y/Y)
Income tax benefit
-$136K
(87.93%↑ Y/Y)
Net loss
-$644,759K
(-39.06%↓ Y/Y)
Purchases of property and
equipment
$6,469K
(-52.76%↓ Y/Y)
Decrease in cash related
to disposal of a...
-$4,438K
Purchases of investments
$3,806K
Purchases of intangible
assets
$2,158K
(-35.58%↓ Y/Y)
Canceled cashflow
$3,373K
Unearned revenue
-$36,771K
(-31.15%↓ Y/Y)
Lease liabilities
-$19,988K
(-28.28%↓ Y/Y)
Accrued expenses and
other current...
-$7,407K
(-234.21%↓ Y/Y)
Accounts payable
-$2,616K
(-140.65%↓ Y/Y)
Accrued development
expense
-$2,328K
(-781.82%↓ Y/Y)
Revenue
$74,681K
(26.92%↑ Y/Y)
Loss from operations
-$648,132K
(-35.31%↓ Y/Y)
Canceled cashflow
$74,681K
Salaries
$303,478K
(24.99%↑ Y/Y)
Consumables
$102,905K
(32.71%↑ Y/Y)
Depreciation and
amortization
$83,701K
(129.36%↑ Y/Y)
Other segment items
$68,944K
(-24.19%↓ Y/Y)
Discovery
$68,193K
(123.73%↑ Y/Y)
Platform
$49,209K
(209.96%↑ Y/Y)
Clinical development
$46,383K
(6.11%↑ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)